ABOUT CENCORA PHARMALEX
Beginning in January 2024, companies in the PharmaLex family started a journey of rebranding aligned with Cencora, our parent company and a leading global pharmaceutical solutions organization centered on improving lives around the world.
PharmaLex adds to Cencora’s expanding suite of pharma solutions and serves the pharma, biotech, and medtech industries. We guide clients from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-elevated solutions to support clients through the entire product lifecycle.
View our content to discover how our expanded capabilities can help you – or contact a Cencora PharmaLex expert today with any questions.
CONTACT INFORMATION
Cencora PharmaLex
1 W 1st Ave.
Conshohocken, PA 19428
UNITED STATES
GET MORE DETAILS ON OUR SOLUTIONS
-
![GettyImages-891264822 planning, meeting]( "The Benefits Of Engaging In Pre-Approval Information Exchange (PIE)")
Explore the top 3 insights on the impact of pre-approval communication and learn why healthcare decision makers want more pre-approval resources and engagement from manufacturers.
FEATURED INSIGHTS
-
![GettyImages-2160140672-dashboard-laptop-data-charts-hand-coffee-cup]( "Exploring Payer Coverage Of Anti-Obesity Medications")
Understanding payer strategies for anti-obesity drugs is crucial. A recent study investigated commercial formulary trends, confirming cost as a major barrier despite positive patient outcomes.
-
![getty-1311598658-data-analytics]( "Exploring Value-Based Contracting In Rare Diseases")
How are payers using value-based contracts for costly rare disease therapies? Exploratory research sheds light on negotiation frequency, preferred contract types, and internal data management trends.
-
![GettyImages-697650898_medical data]( "5 Questions On Exploring Healthcare Decision-Maker Sentiments")
Research presented at AMCP 2025 uses natural language processing on decision-maker feedback to predict coverage. Learn about the surprising findings and next steps in this Q&A.
EXPLORE OUR THOUGHT LEADERSHIP
Explore the latest insights from the Cencora team.
WEBINARS
-
![GettyImages-1368022904 UK]( "Overview Of The UK's International Recognition Procedure")
Overview Of The UK's International Recognition ProcedureGain clarity on the UK's International Recognition Procedure (IRP). Experts Chris Englerth and Graham Donaldson provide key insights into the process and its impact on pharmaceutical product approvals.
-
![GettyImages-2157709105 data, AI]( "Data Governance And AI In Pharma: Overcoming Challenges In DACH Region")
Data Governance And AI In Pharma: Overcoming Challenges In DACH RegionGain insights from industry experts on the implications of the EU's AI Act for data governance professionals, ensuring your organization remains compliant while leveraging AI's transformative potential.
-
![Cencora - EU HTA Webinar]( "EU HTA – Achieving Broad Access Fast! What Will It Take For Innovative Medicines To Succeed?")
EU HTA – Achieving Broad Access Fast! What Will It Take For Innovative Medicines To Succeed?Discover how to navigate the EU HTAR's Joint Clinical Assessment process. Learn from industry experts about accelerating patient access to innovative medicines in Europe.
WHITE PAPERS
-
![GettyImages-891264822 planning, meeting]( "Why An Integrated Approach Ensures Smooth Entry Into The European Market")
Why An Integrated Approach Ensures Smooth Entry Into The European MarketSimplify your EU launch and boost returns. Learn how to manage regulatory hurdles, access a huge patient population, and gain end-to-end commercial support.
-
![GettyImages-2036497698 clinical lab]( "A CFO's Guide To Driving Growth")
A CFO's Guide To Driving GrowthNavigate the evolving biotech landscape and secure venture capital with insights on strategic partnerships and investor expectations.
-
![GettyImages-1016958284 biosimilar lab]( "20 Years Of Biosimilars: Are We On The Right Track?")
20 Years Of Biosimilars: Are We On The Right Track?Explore the transformative journey of biosimilars, 20 years in. Through industry expert insights collected from a recent panel discussion, explore regulatory hurdles, market shifts, and the path ahead.
PODCASTS
-
![Digital-marketing-GettyImages-1051659276]( "Navigating The Digital Era And Beyond For Engaging Key Decision Makers In Specialty Pharmacy")
Navigating The Digital Era And Beyond For Engaging Key Decision Makers In Specialty PharmacyTune in as experts discuss how biopharma companies can effectively engage healthcare decision-makers in the evolving digital landscape.
-
![Cencora PharmaLex - PlX talks 30]( "An Overview Of Contamination Control Strategy (CCS)")
An Overview Of Contamination Control Strategy (CCS)Join experts Londa Ritchey and Patrick Nieuwenhuizen as they explore the key role of a contamination control strategy in Annex 1 for ensuring patient safety and continuous manufacturing improvement.
-
![Cencora - PharmaLex Talks 27]( "Assessing Gaps And Achieving Compliance With Annex 1")
Assessing Gaps And Achieving Compliance With Annex 1In this podcast episode on Annex 1 compliance and gap assessment, Patrick Nieuwenhuizen shares his insights and expertise gleaned from extensive experience in pharmaceutical regulation and compliance.
